Equality
Better Health
For Everyone
Innovation
Inspiring Tomorrow's
Solutions Today
Quality
Elevating Standards,
Ensuring Excellence
Sustainability
Think Sustainable,
Act Responsible
Better Health
For Everyone
Inspiring Tomorrow's
Solutions Today
Elevating Standards,
Ensuring Excellence
Think Sustainable,
Act Responsible
PHYLACTICS is a cutting-edge R&D company dedicated to pioneering innovative technologies in the realm of advanced healthcare solutions to promote health equality. Our focus revolves around developing holistic and economical solutions to address fundamental healthcare needs that promotes health equality in disadvantageous (social/physical/mental/economical) groups like women, elderly and those with special needs. We address three key areas: prophylactic, diagnostic and management solutions all designed to enhance the quality of care. At Phylactics, we are committed to revolutionize the healthcare equality by delivering impactful and sustainable holistic health solutions that improve the well-being of communities everywhere.
It is estimated that about 1 in 6 person is neurodiverse and needs better technological and health support in fostering inclusivity and improving quality of life. As special needs child’s parents, we feel the urge to develop medical innovations to address the unique needs and challenges for diverse neurological conditions such as autism and ADHD. There’s also an increasing number of people, including the loved ones of neurodiverse people, that face mental health challenges such as stress, anxiety and depression. We strive to develop technologies for efficient diagnosis (leading to quicker intervention), risk assessment of drugs and improvised holistic health for better quality of life. By enhancing understanding and support for neurodiverse populations, these technologies promote acceptance, autonomy, and participation in society. They signify a shift towards equitable healthcare, emphasizing the value of embracing neurological differences and ensuring equal opportunities for all.
Early and at home diagnosis is the key for improving public health and democratizing healthcare access as they enable individuals to monitor their health conveniently, reducing the burden on healthcare systems and enhancing preventive care. This is particularly true for women, elderly and those with special needs (physical, mental and economic). Our technology addresses these challenges especially in mitigating problems such as urinary tract infections (UTI), blood and lipid profile, ovarian/reproductive health, hormonal imbalance, menopause and other broad range of health topics. By offering rapid, results and at-home monitoring capabilities, we aim to facilitate early/timely interventions, personalized risk assessment and health improvements to promote health equity, patient autonomy, and overall well-being on a global scale.
Unique biological differences and sociocultural factors prevent women and girls to benefit from quality health services and attaining the best possible level of health. We are expanding the horizons of women’s health beyond women's reproductive health and broadening it to the overall health of women with our holistic health approach including mental health of women. Women are at higher risk than men foranxiety, depression, and psychosomatic complaints. Almost 25% of women will experience mental health issues over their lifetime. We are working on developing easy to use and economical technologies to diagnose, prevent and manage women’s health issues from the privacy of one’s own home. These technologies are designed to empower women to take control of their health, improve quality of life by decreasing the complexity and time spent to access healthcare, and measurably improve health outcomes.
It is estimated that about 1 in 6 person is neurodiverse and needs better technological and health support in fostering inclusivity and improving quality of life. As special needs child’s parents, we feel the urge to develop medical innovations to address the unique needs and challenges for diverse neurological conditions such as autism and ADHD. There’s also an increasing number of people, including the loved ones of neurodiverse people, that face mental health challenges such as stress, anxiety and depression. We strive to develop technologies for efficient diagnosis (leading to quicker intervention), risk assessment of drugs and improvised holistic health for better quality of life. By enhancing understanding and support for neurodiverse populations, these technologies promote acceptance, autonomy, and participation in society. They signify a shift towards equitable healthcare, emphasizing the value of embracing neurological differences and ensuring equal opportunities for all.
Autism | ADHD | Autism Diagnosis | AI Integration | Chronic Constipation | UTI | Eczema | Anxiety
Early and at home diagnosis is the key for improving public health and democratizing healthcare access as they enable individuals to monitor their health conveniently, reducing the burden on healthcare systems and enhancing preventive care. This is particularly true for women, elderly and those with special needs (physical, mental and economic). Our technology addresses these challenges especially in mitigating problems such as urinary tract infections (UTI), blood and lipid profile, ovarian/reproductive health, hormonal imbalance, menopause and other broad range of health topics. By offering rapid, results and at-home monitoring capabilities, we aim to facilitate early/timely interventions, personalized risk assessment and health improvements to promote health equity, patient autonomy, and overall well-being on a global scale.
UTI | Infections | Blood and Lipid Profile | Mental Health Biomarkers | Telehealth | Austere Settings
Unique biological differences and sociocultural factors prevent women and girls to benefit from quality health services and attaining the best possible level of health. We are expanding the horizons of women’s health beyond women's reproductive health and broadening it to the overall health of women with our holistic health approach including mental health of women. Women are at higher risk than men foranxiety, depression, and psychosomatic complaints. Almost 25% of women will experience mental health issues over their lifetime. We are working on developing easy to use and economical technologies to diagnose, prevent and manage women’s health issues from the privacy of one’s own home. These technologies are designed to empower women to take control of their health, improve quality of life by decreasing the complexity and time spent to access healthcare, and measurably improve health outcomes.
UTI | Fungal Infections | Mental Health | Reproductive Health | Women Empowerment | At-Home Diagnostics | Sex Difference on Health Outcomes
Artificial Intelligence (AI) and Machine Learning (ML) are the latest revolution in better data analysis. We have been developing AL/ML algorithms for automated identification of food contaminants as well as pharmacovigilance and risk assessment/predictions to improve women’s health. We continue to develop innovative AL/ML models for addressing challenges in women’s health, as well as finding technological solutions to help people with neurodiversity and mental health challenges. Additionally, we are using these advanced data analytics approach for enhancing our sensing/biosensing capabilities such as improved medical data processing, reliably detecting multiple markers in a single run, and real-time sentimental analysis.
Our experience with materials and chemistry goes back by two decades where we have used Nanotechnology and polymers formulations for diverse biomedical applications ranging from antibacterial bandages to various (bone, muscle, cartilage, skin and brain) tissue engineering, 3D reconstruction of damaged tissues and complex organs as well as developing portable, wearable sensors that can be used for detection of physiological biomarkers, pathogens (bacteria and viruses) heavy metals, carcinogens and such. We have also extensively worked on materials surface modification to develop coatings that are resistant to water, oil, dust and corrosion. We plan to use these experiences and expertise in creating newer innovations especially in the aforementioned areas.
Innovations that address real-world challenges, including those that we are addressing, needs an amalgamation of multiple disciplines and fields of study. This is why we like to think out of the box and leverage our diverse experience from various fields such as AI/ML, materials chemistry, medicine and engineering to develop biomedical innovations. We are fueled by personal experiences and our passion to help others like us. This is what drives us to develop biomedical innovations that aims improve the quality of lives for individuals, especially women, children and elderly with neurodiversity, mental/physical disability, and/or with economic/social constrains, as we strive for health equality and affordability.
We are passionate about accelerating the development and adoption of new technologies to improve lives. The team has 20+ years of experience in technology transfer and commercialization including intellectual property management and regulatory and quality compliance. The team’s strength lies in knowledge of entrepreneurial ecosystems with a preference on expertise in launching and growing technology startup companies.
R&D (Polymer, Formulations, Infection Resistance, Soft Tissue Implants/Grafts, Wound Healing, 3D Tissue Engineering, Regenerative Medicine, Coatings, Biomaterials), Innovation, Business Strategy, Regulatory & Quality, Technology Transfer
R&D (POC Diagnostics, Food & Water Safety, Bio/Chem Hazard Detection),
AI & ML, Operations & Project Management, Customer & Market Research, Communications & Collaborations
Executive Director,
Science Venture Studio at Winrock International,
Little Rock, Arkansas
Regulatory Affairs & Quality Assurance Advisor,
TMAC,
University of Texas, Arlington
Executive Director,
Office of Entrepreneurship and Innovation,
University of Arkansas, Fayetteville
Army Veterinary Corps Officer (Retd),
Public Supervisor Public Health Veterinarian, USDA (Retd)
Managing Partner,
Coactify
Fort Worth Innovators’ Forum,
President, IpserLab
Assistant Professor,
Biomedical Engineering,
University of Texas, Arlington
Regulatory Affairs & Quality Assurance Advisor,
TMAC,
University of Texas, Arlington
Managing Partner,
Coactify
Fort Worth Innovators’ Forum,
President, IpserLab
Executive Director, Office of Entrepreneurship and Innovation,
University of Arkansas, Fayetteville
Assistant Professor, Biomedical Engineering,
University of Texas, Arlington
Executive Director, Science Venture Studio at Winrock International,
Little Rock, Arkansas
Army Veterinary Corps Officer (Retd),
Public Supervisor Public Health Veterinarian. USDA (Retd)
Assoc. Professor, Dept of Neurology and Neurological Surgery,
UT SouthWestern Medical Center
Ex-Microbiologist
U. S Food and Drug Administration
Intellectual Property, Labor-Employment, Contracts Lawyer
The Law Offices of Nick O'Kelly, PLLC
Assistant Professor, Biomedical Engineering,
University of Texas, Arlington
US Army Medical Research Directorate-Africa Kenya Medical Research Institute
Army Veterinary Corps Officer (Retd),
Public Supervisor Public Health Veterinarian. USDA (Retd)
Professor, Department of Biomedical Sciences University of Delhi, India
Director, Molecular Laboratory, Department of Microbiology S. S Institute of Medical Sciences & Research Center